Share this
Cooley Advises on Series of Life Sciences IPOs
May 30, 2017
FibroGen – $120 Million Shelf Takedown
April 19, 2017
Aquinox – $75 Million Public Offering
October 13, 2016
Eiger – $20 Million Shelf-Takedown
September 1, 2016
Protagonist Therapeutics – $90 Million IPO
August 30, 2016
Aduro Completes $137 Million Initial Public Offering
April 30, 2015
FibroGen Closes Largest Biotech IPO in 12 Years
November 20, 2014
Cooley Advises Versartis on its $145 Million IPO
March 31, 2014
Cooley Advises Aquinox Pharmaceuticals on Initial Public Offering
March 13, 2014
Cooley Advises CHC Group on its $310 Million Initial Public Offering and Refinancing Transactions
January 27, 2014
Cooley Advises zulily on its $253 Million Initial Public Offering
November 25, 2013
Cooley LLP Advises on Two IPOs Named to The Daily Journal's Top 10 California IPOs of 2012 List
February 11, 2013